FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

INNOVA CAPTAB LTD.

NSE : INNOVACAPBSE : 544067ISIN CODE : INE0DUT01020Industry : Pharmaceuticals & DrugsHouse : Private

BSE889.1022.1 (+2.55 %)

PREV CLOSE (Rs.) 867.00

OPEN PRICE (Rs.) 859.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1250

TODAY'S LOW / HIGH (Rs.)858.45 898.00

52 WK LOW / HIGH (Rs.)421.55 1259

NSE890.5021.5 (+2.47 %)

PREV CLOSE( Rs. ) 869.00

OPEN PRICE (Rs.) 873.25

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 48957

TODAY'S LOW / HIGH(Rs.) 859.60 898.30

52 WK LOW / HIGH (Rs.)421.35 1260

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

11.00

Dividend Yield(%)

0.00

TTM EPS (Rs.)

15.63

P/E Ratio

56.87

Book Value (Rs.)

142.06

Face Value (Rs.)

MCap (Rs. in Mn)

50878.68

Price/Earning (TTM)

47.78

Price/Sales (TTM)

5.31

Price/Book (MRQ)

6.26

PAT Margin (%)

7.87

ROCE (%)

14.62

Incorporation Year : 03-01 2005

Management Info :

Manoj Kumar Lohariwala - Chairman Vinay Kumar Lohariwala - Managing Director

Registered Office :

Address : 601, Proxima, Plot No 19,Sector 30 A ,Vashi,
Navi Mumbai,
Maharashtra-400705

Phone : 022 2564 2095

Email : mail@innovacaptab.com

Website : www.innovacaptab.com

Registrars Details :

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

12May Innova Captab informs about board meet
Innova Captab has informed that the meeting of the Board of Directors of..

07Apr Innova Captab informs about certificate
Pursuant to Regulation 74(5) of Securities and Exchange Board of India (..

01Mar Innova Captab submits analyst meet int
Pursuant to the Regulation 30 read with Schedule III (Part A) (15) of th..

Financials

	QTR Mar 25	ANNUAL 25
Net Profit	171.25	894.7
Gross Profit	228.55	1198.91
Operating Profit	325.36	1390.74
Net Sales	2425.22	9580.61

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Emcure Pharma (BSE)

1288.65 (10.00%)

M.Cap (Rs. in Cr)24417.77

Medplus Health Servi (BSE)

950.90 (7.36%)

M.Cap (Rs. in Cr)11381.69

Shilpa Medicare (BSE)

781.50 (6.33%)

M.Cap (Rs. in Cr)7642.36

Orchid Pharma (BSE)

754.40 (4.21%)

M.Cap (Rs. in Cr)3826.25

Shareholding Pattern

	PROMOTERS	50.9%
	NON-INSTITUTION	28.99%
	MUTUAL FUNDS/UTI	10.75%
	FI/BANKS/INSURANCE	1.82%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

Edelweiss Recently ...

2.02

Kotak Consumption F...

1.65

Canara Rob Manufact...

1.58

Invesco India Midca...

1.33

Canara Rob Small Ca...

1.25

Canara Rob Value Fu...

1.20

Kotak Healthcare Fu...

1.07

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22

INNOVA CAPTAB LTD.

Smart Quotes

Attention Investors

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Filing complaints on SCORESEasy & quick

Risk Disclosures On Derivatives